Meeting People Where They Are: Treating HIV, HCV, SUD and Injection Drug Use

Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.

Learning Objectives

1. Describe the American Association for the Study of Liver Diseases and Infectious Diseases Society of America treatment recommendations for HCV.
2. Describe how to make referrals to effective harm reduction services.
3. Describe effective linkage to care models for people co-infected with HIV and HCV.